Orthopedic Surgery, Pediatric Orthopedic Surgery · Orange, CA
NPI
1235167107
Since 2006
Specialty
Orthopedic Surgery, Pediatric Orthopedic Surgery
Code 207XP3100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1310 W Stewart Dr, Suite 508
Orange, CA, 92868
Phone (714) 633-2111
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,320
101 services
Medicare patients, 2024
44
Average age 40
Drug cost, 2024
$193K
255 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel R Rosenfeld was code 99213 (office e&m - established), 71 times for 39 patients. In total Samuel R Rosenfeld billed 101 services in 15 codes, and Medicare paid $6,320.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 71 | 39 | $66.50 | $4,721 |
By year: 2022 $7,719 for 122 services; 2023 $7,300 for 97 services; 2024 $6,320 for 101 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel R Rosenfeld prescribed most often to Medicare patients was Gabapentin, with 78 prescriptions and refills. In total Samuel R Rosenfeld wrote 255 Medicare prescriptions that cost $193K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 78 | 110 | 12 | $1,529 |
| Baclofen Generic | 50 | 111 | 12 | $2,132 |
| Trihexyphenidyl Hcl Generic | 31 | 51 | Under 11 | $433 |
| Ssd Silver Sulfadiazine | 19 | 19 | Under 11 | $611 |
| Calcitriol Generic | 16 | 28 | Under 11 | $286 |
| Emflaza Deflazacort | 12 | 12 | Under 11 | $188K |
| Glycopyrrolate Generic | 11 | 11 | Under 11 | $263 |
Brand drugs: 31 claims; generic drugs: 224 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Samuel R Rosenfeld were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.